GBIM

GlobeImmune, Inc. [GBIM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

GBIM Stock Summary

In the News

GBIM Financial details

Company Rating
-
Market Cap
8.05M
Income
-2.07M
Revenue
6.21M
Book val./share
0.37
Cash/share
1.51
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
12 May 2016
P/E
0
Forward P/E
-
PEG
-
P/S
7171720.2
P/B
-
P/C
0
P/FCF
-1.12
Quick Ratio
2.34
Current Ratio
2.62
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.22
EPS next Y
-
EPS next Q
-
EPS this Y
-93.87%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-68.98%
Revenue last 5Y
4.8%
Revenue Q/Q
-10.04%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-24%
ROE
-64%
ROC
-0.38%
Gross Margin
100%
Oper. Margin
-43%
Profit Margin
-43%
Payout
-
Shs Outstand
10.07B
Shs Float
4.37M
-
-
-
-
Target Price
-
52W Range
5.0E-4-8.0E-4
52W High
-
52W Low
-
RSI
6.29
Rel Volume
-
Avg Volume
263
Volume
Perf Week
0%
Perf Month
-12.5%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-178.922
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0007
Change
0%

GBIM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2015-12-31

Metric History 2011-12-312012-12-312013-12-312014-12-31 2015-12-31
Revenue per share
53.42153.12235.492.051.12
Net income per share
-167.22-0.6699.11-7.83-0.48
Operating cash flow per share
-52.34-136.6641.12-3.45-1.24
Free cash flow per share
-53.73-137.840.99-3.55-1.25
Cash per share
158.4820.9561.955.771.72
Book value per share
-1.91K-2.05K-2.08K1.920.52
Tangible book value per share
-1.91K-2.05K-2.08K1.920.52
Share holders equity per share
-1.91K-2.05K-2.08K1.920.52
Interest debt per share
00-17.851.330
Market cap
1.06M1.06M1.06M22.12M22.26M
Enterprise value
-14.1M-946.32K-4.67M5.31M12.36M
P/E ratio
-0.07-16.770.11-0.97-8.04
Price to sales ratio
0.210.070.053.713.45
POCF ratio
-0.21-0.080.27-2.2-3.12
PFCF ratio
-0.21-0.080.27-2.14-3.11
P/B Ratio
-0.01-0.01-0.013.957.45
PTB ratio
-0.01-0.01-0.013.957.45
EV to sales
-2.76-0.06-0.210.891.91
Enterprise value over EBITDA
1.340.31-0.55-0.96-4.79
EV to operating cash flow
2.820.07-1.19-0.53-1.73
EV to free cash flow
2.740.07-1.19-0.51-1.72
Earnings yield
-15.13-0.068.97-1.03-0.12
Free cash flow yield
-4.86-12.473.71-0.47-0.32
Debt to equity
00000
Debt to assets
000.0300
Net debt to EBITDA
1.440.66-0.683.043.84
Current ratio
1.160.351.063.442.62
Interest coverage
00-4.04-1.50
Income quality
0.366.490.410.622.58
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.410.140.720.71
Research and developement to revenue
2.360.80.481.210.69
Intangibles to total assets
00000
Capex to operating cash flow
0.030.0100.030.01
Capex to revenue
-0.03-0.010-0.05-0.01
Capex to depreciation
-0.14-0.12-0.02-1-0.19
Stock based compensation to revenue
0.060.030.010.010.02
Graham number
2.68K174.372.16K18.42.37
ROIC
1.060.05-1.230.520.32
Return on tangible assets
-0.9-0.011.28-1.24-0.24
Graham Net
-1.93K-2.07K-2.1K1.390.24
Working capital
2.13M-5.46M410.64K12.64M6.87M
Tangible asset value
-182.4M-196.12M-199.32M5.6M2.99M
Net current asset value
-184.57M-197.48M-199.91M5.05M2.57M
Invested capital
00000
Average receivables
00000
Average payables
1.22M2.14M2.35M1.15M403.33K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0.090-0.05-4.07-0.93
Capex per share
-1.39-1.14-0.13-0.1-0.01

Quarterly Fundamentals Overview

Last date of statement is 2016-03-31 for Q1

Metric History 2015-03-312015-06-302015-09-302015-12-31 2016-03-31
Revenue per share
0.210.220.5100.16
Net income per share
-0.27-0.230.160-0.15
Operating cash flow per share
-0.42-0.34-0.230-0.21
Free cash flow per share
-0.43-0.35-0.230-0.21
Cash per share
2.52.151.9601.51
Book value per share
0.710.490.6500.37
Tangible book value per share
0.710.490.6500.37
Share holders equity per share
0.710.490.6500.37
Interest debt per share
00000
Market cap
42.22M15.01M15.01M012.02M
Enterprise value
27.86M2.65M3.72M-9.9M3.33M
P/E ratio
-6.76-2.884.20-3.49
Price to sales ratio
35.5411.755.1012.75
POCF ratio
-17.36-7.58-11.480-9.96
PFCF ratio
-17.19-7.54-11.460-9.96
P/B Ratio
10.315.29405.59
PTB ratio
10.315.29405.59
EV to sales
23.452.071.26-9.453.53
Enterprise value over EBITDA
-18.81-2.144.0712.77-3.95
EV to operating cash flow
-11.46-1.34-2.847.03-2.76
EV to free cash flow
-11.34-1.33-2.847.03-2.76
Earnings yield
-0.04-0.090.060-0.07
Free cash flow yield
-0.06-0.13-0.090-0.1
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
9.6910-12.3612.7710.31
Current ratio
3.272.762.962.622.28
Interest coverage
00000
Income quality
1.561.52-1.461.771.4
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
10.920.351.10.99
Research and developement to revenue
1.241.040.340.640.9
Intangibles to total assets
00000
Capex to operating cash flow
0.010.01000
Capex to revenue
-0.02-0.01000
Capex to depreciation
-0.3-0.15-0.0800
Stock based compensation to revenue
0.040.030.010.030.03
Graham number
2.091.591.5101.12
ROIC
0.110.11-0.090.090.11
Return on tangible assets
-0.1-0.10.07-0.07-0.09
Graham Net
0.520.290.3200.19
Working capital
10.38M8.36M8.53M6.87M5.3M
Tangible asset value
4.1M2.84M3.75M2.99M2.15M
Net current asset value
3.6M2.39M3.42M2.57M1.83M
Invested capital
00000
Average receivables
00000
Average payables
549.57K615.24K494.76K259.83K320.87K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.38-0.460.24-0.27-0.4
Capex per share
00000

GBIM Frequently Asked Questions

What is GlobeImmune, Inc. stock symbol ?

GlobeImmune, Inc. is a US stock , located in Louisville of Co and trading under the symbol GBIM

What is GlobeImmune, Inc. stock quote today ?

GlobeImmune, Inc. stock price is $0.0007 today.

Is GlobeImmune, Inc. stock public?

Yes, GlobeImmune, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Price Range
Similar Market Cap